News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.
8 hrs ago | Business Wire
The Rating Outlook remains St... China Sees More Currency Volatility as Central Bank Seeks to Discourage Idea That Yuan is a "One-Way Trade," Says Market Vectors' Rodilosso )--New willingness from the Chinese Central Bank to let the renminbi depreciate could fundamentally alter what had been a "one-way" trade, and fixed income ETF PM Fran Rodil...
Trending on the Topix Network
12 hrs ago | Reuters
Pfizer Inc said on Thursday it was recalling two lots of its Effexor XR antidepressant and another lot of its generic version of the drug after a pharmacist reported finding one capsule of a different medicine in a bottle of Effexor.
16 hrs ago | GuruFocus.com
Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings filed by institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission .
We recently posted about the influx of new general counsel at about 10% of large organizations , and the expected corollary to that is former general counsel are leaving those positions.
It has also rolled two prior agency acquisitions, TargetCast and RJ Palmer, into a new, 250-person-strong media agency called Assembly, which will function as a unit within MDC Media Partners.
"This collaboration is a natural fit with our mission to develop therapies for patients with severe neurodegenerative diseases," said Biogen CEO George Scangos.
The Wall Street Bull Market Express is leaving the station and you have two months, maybe three to run down the platform, take the leap, and latch on to the caboose.
Pfizer is a biopharmaceutical company that discovers, develops, manufactures, and sells medicines for people and animals worldwide.
More detailsa . Stock Symbols: Help employers find you! Check out all the jobs and post your resume .
The rising importance of in-house lawyers at major corporations may set them up for a fall.
DIA today announced that two worldwide leaders in the pharmaceutical and medical product development will co-chair the DIA 2014 50th Annual Meeting June 15-19 at the San Diego Convention Center.
Reformulating old molecules in the pain pipeline, however, won't offset sales erosion of the drugmaker's fourth best-selling product - which still managed 6% global growth year-over-year - to generic competitors.
Looking backward to improve its future, Pfizer will once again try to gain FDA approval to market its blockbuster drug, atorvastatin , over-the-counter .
Pfizer recently started a 1,200-patient clinical trial to test if consumers taking a nonprescription Lipitor get their own blood tests to see if the medicine is improving their cholesterol and then make the right decisions based on the results.
Scientists have uncovered gene mutations that slash the risk of Type 2 diabetes regardless of age and weight, offering drugmakers a novel target to combat one of the major health threats confronting the modern world.